“Mean Percentage Improvement in Psoriasis Area and Severity Index (PASI) Response and Absolute PASI Through 5 Years of Continuous Treatment With Guselkumab (GUS) in VOYAGE 1 ”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 2, Mar. 2022, p. s3, https://doi.org/10.25251/skin.6.supp.3.